December 2012 | BayernLB Capital Partner |
Industrials and Capital Goods |
FERBER & CO. advised Bayern LB Capital Partner GmbH
and the minority shareholders on the sale of its shares in Rebhan FPS Kunststoff-Verpackungen GmbH to Certina Holding AG. |
 |
|
February 2021 |
Shareholders of teamtechnik Maschinen und Anlagen GmbH |
Industrials and Capital Goods |
FERBER & CO. advised the shareholders of teamtechnik Maschinen und Anlagen GmbH on the sale of a 75% majority interest to Dürr group. |
 |
December 2020 |
Permira |
Healthcare |
FERBER & CO. advised Permira on the aquisition of Neuraxpharm from Apax Partners. |
 |
December 2020 |
Oakley Capital |
Healthcare |
FERBER & CO. advised Oakley Capital on the acquisition of WindStar Medical GmbH from ProSiebenSat.1 majority-owned NuCom Group. |
 |
November 2020 |
Cornerstone Capital and the minority shareholders |
Industrials and Capital Goods |
FERBER & CO. advised Cornerstone Capital together with the minority shareholders on the sale of 100% of the shares in EppsteinFoils to Artum AG. |
 |
September 2020 |
EOS AG and the founding shareholders |
Industrials and Capital Goods |
FERBER & CO. advised EOS AG and the founding shareholders on the sale of 100% of the shares in Microbeads A/S to Lamberti group. |
 |
September 2020 |
Shareholders of Bader Holding GmbH |
Industrials and Capital Goods |
FERBER & CO. advised the shareholders of Bader Holding GmbH, Senden on the sale of selective manufacturing subsidiaries and operating assets of the Bader Group, a leading supplier of machine covers and housings to the European machinery industry, to a group of investors led by GFEP GmbH. |
 |
August 2020 |
Heinz-Peter Fichter and Apotal group |
Healthcare |
FERBER & CO. advised Heinz-Peter Fichter and Apotal group on the sale of Apotal's mail-order pharmaceuticals and diabetes activities to Zur Rose group. |
 |
April 2020 |
Capiton and Alphapet Ventures |
Consumer Goods and Retail |
FERBER & CO. advised Capiton and Alphapet Ventures on the realignment of the shareholder base as part of the combination of Alphapet Ventures and Healthfood 24 (Wolfsblut) in the premium pet food segment. |
 |
April 2020 |
Alphapet Ventures |
Consumer Goods and Retail |
FERBER & CO. advised Alphapet Ventures to secure funding for its acquisition of Healthfood24 (Wolfsblut) through equity financing. |
 |
March 2020 |
Dermapharm AG |
Healthcare |
FERBER & CO. advised Dermapharm on the acquisition of Allergopharma GmbH & Co. KG, a subsidiary of Merck KGaA. |
 |